Le bâillement, du réflexe à la pathologie
Le bâillement : de l'éthologie à la médecine clinique
Le bâillement : phylogenèse, éthologie, nosogénie
 Le bâillement : un comportement universel
La parakinésie brachiale oscitante
Yawning: its cycle, its role
Warum gähnen wir ?
 
Fetal yawning assessed by 3D and 4D sonography
Le bâillement foetal
Le bâillement, du réflexe à la pathologie
Le bâillement : de l'éthologie à la médecine clinique
Le bâillement : phylogenèse, éthologie, nosogénie
 Le bâillement : un comportement universel
La parakinésie brachiale oscitante
Yawning: its cycle, its role
Warum gähnen wir ?
 
Fetal yawning assessed by 3D and 4D sonography
Le bâillement foetal
http://www.baillement.com

mystery of yawning 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

haut de page

 

 

 

 

 

 

 

 

mise à jour du
29 juillet 2026
Front Neurol
2026;17:1824166
 
Scholarpedia
Impact of Parakinesia brachialis oscitans on limb functional recovery after stroke: a cohort study
Wang C, Hu H, Wang R, Xu B, Du J, Su Z,
Guo S, Wang J, Tian X.

Chat-logomini

 
Tous les articles sur la parakinésie brachiale oscitante 
 
All articles about parakinesia brachialis oscitans 

Parakinesia brachialis oscitans (PBO), involuntary elevation of the paralyzed upper limb during yawning is a rare phenomenon after ischemic stroke, but its prognostic significance remains unclear due to limited systematic studies.

Objective: To compare 3-month motor recovery between ischemic stroke patients with PBO, without PBO, and with spontaneously resolved PBO using a propensity score-matched design.

Methods: This retrospective cohort study included 33 patients with PBO identified in the database as the PBO group, while the non-PBO group was selected from patients with acute ischemic stroke between March and June 2024. Two independent neurologists reviewed medical records according to standardized criteria to identify PBO (within 7_days of stroke onset) and collected baseline data from all patients within 24_h of stroke onset. PSM (1:2) was used to balance baseline characteristics (age, sex, vascular risk factors, stroke location, ASPECTS score, baseline Lovett score, and FMA score) between the PBO and non-PBO groups. The primary outcome was the FMA score at 3_months; the secondary outcome was the Lovett classification. All outcome assessors were blinded.

Results: After matching, 26 PBO patients were matched to 52 non-PBO patients with balanced baseline characteristics. At 3_months, the PBO group showed significantly higher FMA scores (mean difference 3.77, 95% CI: _0.54&endash;6.97; p_=_0.022) and Lovett grades (p_=_0.018) than the non-PBO group. Among PBO patients, the PBO disappearance group (n_=_19) within 1_month achieved higher FMA scores than the PBO persistence group (n_=_14) (mean difference 7.11, 95% CI: _13.10&endash;-1.06; p_=_0.021), whereas Lovett grades did not differ significantly (p_=_0.111).

Conclusion: In this propensity-score-matched cohort study, the presence of PBO was associated with better recovery of motor function at 3_months. Early spontaneous resolution of PBO was associated with better fine motor outcomes compared to persistent PBO. These findings, which support the hypothesis, suggest that PBO may serve as a potential prognostic indicator warranting further prospective research.
 
La parakinésie brachiale oscitante (PBO), c'est-à-dire l'élévation involontaire du membre supérieur paralysé lors d'un bâillement, est un phénomène rare après un AVC ischémique, mais sa signification pronostique reste incertaine en raison du nombre limité d'études systématiques.
 
Objectif : Comparer la récupération motrice à 3 mois chez les patients victimes d'un AVC ischémique présentant une PBO, ne présentant pas de PBO et chez ceux dont la PBO s'est résolue spontanément, à l'aide d'une méthode d'appariement par score de propension.
 
Méthodes : Cette étude de cohorte rétrospective a inclus 33 patients présentant une PBO, identifiés dans la base de données comme constituant le groupe PBO, tandis que le groupe non-PBO a été sélectionné parmi les patients ayant subi un AVC ischémique aigu entre mars et juin 2024. Deux neurologues indépendants ont examiné les dossiers médicaux selon des critères standardisés afin d'identifier les cas de PBO (survenus dans les 7 jours suivant le début de l'AVC) et ont recueilli les données de base de tous les patients dans les 24 heures suivant le début de l'AVC. Un appariement par score de propension (PSM, rapport 1:2) a été utilisé pour équilibrer les caractéristiques de base (âge, sexe, facteurs de risque vasculaires, localisation de l'AVC, score ASPECTS, score de Lovett initial et score FMA) entre les groupes PBO et non-PBO. Le critère de jugement principal était le score FMA à 3 mois ; le critère de jugement secondaire était la classification de Lovett. Tous les évaluateurs des critères de jugement étaient en aveugle.
 
Résultats : Après appariement, 26 patients du groupe PBO ont été appariés à 52 patients du groupe non-PBO présentant des caractéristiques de base équilibrées. À 3 mois, le groupe PBO présentait des scores FMA (différence moyenne de 3,77, IC à 95 % : _0,54 à 6,97 ; p = 0,022) et des grades de Lovett (p = 0,018) significativement plus élevés que le groupe non-PBO. Parmi les patients sous PBO, le groupe présentant une disparition de la PBO (n = 19) en moins d'un mois a obtenu des scores FMA plus élevés que le groupe présentant une persistance de la PBO (n = 14) (différence moyenne de 7,11, IC à 95 % : _13,10 à _1,06 ; p = 0,021), tandis que les grades de Lovett ne présentaient pas de différence significative (p = 0,111).
 
Conclusion : Dans cette étude de cohorte appariée par score de propension, la présence d'un PBO était associée à une meilleure récupération de la fonction motrice à 3 mois. La résolution spontanée précoce de la PBO était associée à de meilleurs résultats en matière de motricité fine par rapport à une PBO persistante. Ces résultats, qui corroborent l'hypothèse, suggèrent que la PBO pourrait constituer un indicateur pronostique potentiel justifiant la poursuite de recherches prospectives.

Introduction
Ischemic stroke is the most common disabling disease in China. With the acceleration of population aging, its incidence continues to rise, with over 3 million new cases annually (1). The resulting loss of working capacity imposes significant life and economic burdens on patients and their families. Early rehabilitation therapy, particularly limb function rehabilitation, significantly impacts patients' subsequent quality of life (2). 70 to 80% of patients experience varying degrees of motor impairment, and 50 to 60% of patients continue to have functional impairments 6_months later (3).
Parakinesia brachialis oscitans (PBO) refers to the phenomenon where paralyzed limbs exhibit involuntary movement during yawning, observed after neurological damage causes loss of voluntary limb movement. This uncommon occurrence was first termed PBO by Walusinski et al. (4). Current research on PBO, both domestically and internationally, remains limited to scattered case reports and mechanistic hypotheses. Systematic, multimodal explanations of its mechanisms are lacking, and high-level evidence-based medical evidence linking PBO to rehabilitation prognosis is absent (5). Clinically, rehabilitation outcomes for patients exhibiting PBO appear distinct from those without this phenomenon. A previous study indicated that 25% of patients with PBO remained paralyzed, while the others regained varying degrees of limb mobility; only 5% regained hand function (6). The PBO phenomenon may serve as a clinical biomarker capable of predicting a patient's potential for functional recovery, guiding the timing and intensity of rehabilitation interventions to achieve better functional outcomes. Against this backdrop, we conducted a cohort study to investigate whether the presence of PBO, as well as its persistence versus resolution within the first month post-stroke, is associated with differences in functional recovery (assessed at 3_months) in patients with ischemic stroke.
 
DISCUSSION
PBO represents a distinct and often overlooked clinical manifestation in stroke patients with hemiplegia, characterized by involuntary elevation of the paralyzed limb during yawning (12). Previous studies have primarily consisted of a small number of case reports; as shown in Table 5, these reports have proposed possible pathophysiological mechanisms, but no studies have specifically examined the relationship between this phenomenon and functional outcomes (13&endash;16). Among the 33 patients exhibiting PBO in this study, 31 demonstrated involuntary elevation solely in the upper limb, while 2 exhibited simultaneous elevation in both upper and lower limbs. Given this phenomenon, the study analyzed only upper limb function using the Lovett classification and FMA score. The Lovett classification is frequently used clinically for its intuitive assessment of limb functional changes. The FMA score quantifies upper limb motor ability through various movements, providing more accurate evaluation of fine motor skills (17). Yawning is a complex physiological behavior involving multi-level neural regulation: its initiation and control primarily rely on the paraventricular nucleus of the hypothalamus, which projects signals via oxytocinergic, cholinergic, and other neuronal groups to the hippocampus, brainstem (pons, medulla), and even the spinal cord (18). Pathological or excessive yawning represents a clinically significant manifestation following acute stroke. Research indicates it frequently signals damage to the brainstem reticular formation or cortical/subcortical regions (particularly the insula and caudate nucleus). This demonstrates direct overlap between the neural pathways governing yawning and the lesion site in stroke (19).
Due to the relatively low incidence of PBO, this study employed PSM to select patients with comparable baseline characteristics for comparison with the PBO cohort, ensuring research rigor (20). A total of 33 PBO patients were recorded, matched 1:2 via PSM, resulting in 26 patients (PBO group) matched to 52 corresponding patients (non-PBO group). Further analysis revealed that at 3_months, the PBO group demonstrated statistically significant superiority over the non-PBO group in Lovett muscle strength grading and FMA scores (p_<_0.05). In previous case reports, several neurophysiological hypotheses have been proposed, including three main hypotheses: the disinhibition of cortical-to-subcortical motor pathways, the activation of the extrapyramidal motor-emotional system, and proprioceptive feedback transmitted via the cerebellar-brainstem-spinal cord circuit; all of these may contribute to the occurrence of involuntary limb movements during yawning, as shown in Figure 3 (21&endash;23). However, these mechanisms were not directly tested in the present study. Our findings are primarily interpreted at the clinical association level, rather than as mechanistic evidence. Regardless of the hypothesis, the occurrence of PBO suggests that primitive motor networks at the brainstem and spinal cord level remain relatively intact or exhibit heightened excitability. These networks include the reticulospinal system and cerebellar-brainstem connections, and their preservation occurs despite disruption of the corticospinal tract, which serves as the primary descending motor pathway. In this study, patients in the PBO group demonstrated significantly superior muscle strength and motor function scores at 3_months compared to the non-PBO group, suggesting that PBO may represent an observable clinical sign associated with the integrity and excitability of primitive motor pathways. The PBO phenomenon is compatible with the hypothesis that the lower-level motor centers in the brainstem and spinal cord retain functional integration capabilities and that neural connections to limb muscles remain partially intact. The ability to perform the complex coordinated movement of PBO may indicate that the "alternative pathway" from the brainstem to the anterior horn cells of the spinal cord is structurally preserved and functionally activatable. Compared to non-PBO patients, those exhibiting PBO possess more complete "neurological reserve." During the process of neural reorganization following a stroke, these preserved and activatable primitive pathways provide a potential anatomical and physiological basis for the recovery of motor function. Rehabilitation training may be able to leverage these pathways to compensate for the impaired function of the corticospinal tract, thereby achieving superior functional recovery outcomes.
Literature reports suggest that PBO may be associated with poor patient outcomes (12). We classified patients whose PBO resolved within 1 month post-stroke as the disappearance group and those with persistent PBO as the persistence group. Statistical analysis of Lovett muscle strength grades and FMA scores between the two groups after stroke revealed no statistically significant difference (p_>_0.05). Three_months later, the FMA scores in the disappearance group were significantly higher than those in the persistence group (p_<_0.05). There was no statistically significant difference in Lovett muscle strength grading between the two groups (p_>_0.05). In this study, the FMA score focuses more on evaluating isolated movements, coordination, and fine motor control, which are highly dependent on the integrity of the corticospinal tract (24). The Lovett scale provides a relatively coarse ordinal estimate of muscle strength, mainly reflecting the ability to move against gravity or resistance, and may be less sensitive to subtle improvements in selective motor control, coordination, and distal upper-limb performance (25). Compared to the FMA, the Lovett scale is less sensitive as a measure of physical fitness when assessing changes in athletic ability. The higher FMA scores in the disappearance group suggest better recovery of corticospinal tract function. Regarding this outcome, we venture the hypothesis that the persistent PBO phenomenon may serve as a clinical marker of the motor system's failure to transition successfully from a "lower-level compensatory mode" to a "higher-level dominant mode" post-stroke. This may indicate that neural remodeling has become stuck in an inefficient plateau phase. The superior function in the disappearance group likely stems not only from the "re-inhibition" of lower-level centers following corticospinal tract recovery but also from an active, successful "functional hierarchical transition" process. In the persistent PBO group, impaired recovery of the corticospinal tract leaves lower pathways persistently overactive and "unleashed" due to lack of higher-level control. This state itself may hinder corticospinal reorganization through mechanisms like synaptic competition, creating a vicious cycle (26). Consequently, functional recovery remains stalled at a plateau, preventing further improvement.
The early disappearance of PBO may indicate successful remodeling of corticospinal tract function and the "return" of higher-level motor control, signaling that the nervous system is progressing toward a more optimal functional reorganization. However, at present, these observations should not be taken as evidence to modify rehabilitation intensity or timing in routine clinical practice. Rather, they suggest that PBO status may be worth evaluating as a stratification variable in future prospective or interventional rehabilitation studies.
In this PSM retrospective cohort, the presence of PBO after ischemic stroke was associated with better 3-month motor outcomes, as reflected by higher Lovett grades and FMA scores compared with matched patients without PBO. Among patients with PBO, early disappearance of the phenomenon within 1_month was associated with better 3-month FMA performance than persistent PBO. These findings suggest that PBO may be a clinically observable sign associated with short-term motor recovery trajectory after stroke.
Several methodological limitations should be considered. First, this was a retrospective single-center study, which may limit generalizability. Second, follow-up was limited to 3_months, and therefore longer-term recovery trajectories could not be evaluated. Third, although all patients received rehabilitation management, the content, intensity, frequency, and adherence of rehabilitation interventions during follow-up were not standardized or quantitatively captured, which may have influenced functional outcomes. Fourth, there were marked baseline differences in functional severity before matching, and baseline severity-related variables played an important role in the PSM process. While this approach improved comparability, it may also affect the interpretation of between-group outcome differences and reduce the representativeness of the matched sample relative to the source population.
Residual confounding cannot be excluded despite PSM, because matching can only address measured variables. Unmeasured or incompletely measured factors, such as detailed lesion burden, corticospinal tract integrity, acute treatment characteristics, and rehabilitation exposure, may still have influenced the observed associations, particularly given the modest sample size and limited subgroup numbers. This is a retrospective observational study design;the present study relied primarily on clinical functional scales without complementary objective biomarkers, such as lesion-specific imaging analyses, diffusion-based assessment of corticospinal tract integrity, or electrophysiological measures. Whether PBO can be considered a valid prognostic marker requires larger-scale, multicenter, prospective studies with longer follow-up periods and multimodal assessments of the underlying mechanisms. Future research should aim to employ multimodal neuroinformation fusion (synchronous acquisition and analysis of high-resolution MRI, electroencephalography, surface electromyography) to quantitatively analyze PBO-specific neural circuit characteristics.